This episode features Chris Carmody, Chief Technology Officer at UPMC. Here, he discusses his background & the evolution of technology throughout his career, UPMC’s clinical analytics program, how he is thinking about growth and adding value at UPMC, and more.…

In this episode we are joined by Dr. Robert McDermott, Allergist/Immunologist, Allergy, Asthma & Immunology of the Rockies PC part of the Allervie network, to discuss how allergists are utilizing AI-powered technologies to close the gap between clinical conversation and…

This episode features Salim Saiyed, MD, FAMIA, Vice President, Chief Medical Information Officer, Diplomate Clinical Informatics at UPMC Central Pa. Here, he discusses his background & responsibilities in his current role, opportunities and headwinds he's keeping his eye on, what…

Between staffing shortages and shrinking budgets, healthcare staff are being asked to do more with less. How can IT and training teams better support clinicians in their use of technology when they themselves are often understaffed and working with tight…

Dr. Conrad Gleber and Dr. Kathleen Fear of University of Rochester Medical Center join the podcast to discuss the potential impact of generative AI on healthcare as a whole, the importance of proceeding with caution when implementing new technologies, where…

Epic Systems, the EHR vendor that holds 36% of the acute care hospital market share in the U.S., has gotten high marks regarding its ability to handle data and was able to achieve customer satisfaction with its payer platform.

To unlock an operating room's full potential, building trust and engagement with surgeons is essential.

Emory University, based in Atlanta, has launched the Emory Empathetic AI for Health Institute, an institute dedicated to using artificial intelligence and computing power to extract meaningful insights from massive amounts of data and forecast outcomes that enhance patient well-being…

Greensboro, N.C.-based Cone Health is partnering with Helix, a population genomics company, to launch a population genomics testing program. 

Sangamo Therapeutics, a biotech company developing treatment for genetic conditions, announced that it is laying off 162 employees, or 40% of the company's U.S. workforce, as the company looks to restructure and focus on the creation of neurological treatments.